Andrew Skelton

ORCID: 0000-0002-1094-6217
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Osteoarthritis Treatment and Mechanisms
  • Cancer-related molecular mechanisms research
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Cytokine Signaling Pathways and Interactions
  • Immunodeficiency and Autoimmune Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • T-cell and B-cell Immunology
  • interferon and immune responses
  • Epigenetics and DNA Methylation
  • Lymphoma Diagnosis and Treatment
  • Cancer-related gene regulation
  • Immune Cell Function and Interaction
  • MicroRNA in disease regulation
  • Salivary Gland Disorders and Functions
  • Chronic Lymphocytic Leukemia Research
  • Mycobacterium research and diagnosis
  • Circular RNAs in diseases
  • Psoriasis: Treatment and Pathogenesis
  • Protease and Inhibitor Mechanisms
  • Molecular Biology Techniques and Applications
  • Cell Adhesion Molecules Research
  • RNA modifications and cancer
  • IL-33, ST2, and ILC Pathways
  • Genetics and Neurodevelopmental Disorders

UCB Pharma (United Kingdom)
2019-2025

UCB Pharma (Belgium)
2023-2024

Newcastle University
2015-2023

Amsterdam University Medical Centers
2023

University Medical Center Utrecht
2023

Centre for Life
2019

NIHR Newcastle Biomedical Research Centre
2015-2019

Newcastle upon Tyne Hospitals NHS Foundation Trust
2015-2019

National Institute for Health Research
2015-2019

Versus Arthritis
2018

Abstract Autoimmunity can occur when a checkpoint of self-tolerance fails. The study familial autoimmune diseases reveal pathophysiological mechanisms involved in more common diseases. Here, by whole-exome/genome sequencing we identify heterozygous, autosomal-dominant, germline loss-of-function mutations the SOCS1 gene ten patients from five unrelated families with early onset manifestations. intracellular protein is known to downregulate cytokine signaling inhibiting JAK-STAT pathway....

10.1038/s41467-020-18925-4 article EN cc-by Nature Communications 2020-10-21
Jessica Tarn Nadia Howard-Tripp Dennis Lendrem Xavier Mariette Alain Saraux and 95 more Valérie Devauchelle‐Pensec Raphaèle Séror Andrew Skelton Katherine James Peter McMeekin Shereen Al-Ali Katie L. Hackett Clare Lendrem Ben Hargreaves John Casement Sheryl Mitchell Simon J Bowman Elizabeth Price Colin Pease Paul Emery Peter Lanyon John Hunter Monica Gupta Stefano Bombardieri Nurhan Sutcliffe Costantino Pitzalis John McLaren Annie Cooper Marian Regan Ian Giles David Isenberg V. Saravanan David Coady Bhaskar Dasgupta Neil McHugh Steven Young‐Min Robert J. Moots Nagui Gendi Mohammed Akil Bridget Griffiths Svein Joar Auglænd Johnsen Katrine Brække Norheim Roald Omdal Deborah Stocken Colin Everett Catherine Fernandez John D. Isaacs Jacques‐Eric Gottenberg Wan‐Fai Ng Valérie Devauchelle‐Pensec Philippe Dieudé Jean Jacques Dubost Anne-Laure Fauchais Vincent Goëb É. Hachulla C. Larroche Véronique Le Guern Jacques Morel Aleth Perdriger Xavier Puéchal S. Rist Damien Sen Jean Sibilia Olivier Vittecoq Joëlle Bénessiano Sarah Tubiana Karine Inamo Stanie Gaëte Djilali Batouche Domitille Molinari Mickael Randrianandrasana Isabelle Pane Adeline Abbé Gabriel Baron Philippe Ravaud Jacques-Eric Gottenberg Philippe Ravaud Xavier Puéchal Véronique Le Guern Jean Sibilia C. Larroche Alain Saraux Valérie Devauchelle-Pensec Jacques Morel Gilles Hayem P.Y. Hatron Aleth Perdriger Damien Sene Charles Zarnitsky Djilali Batouche Valérie Furlan Joëlle Bénessiano Élodie Perrodeau Raphaèle Séror Xavier Mariette Samuel M. Brown N. Navarro Saaeha Rauz Paul Emery Sue Pavitt

Heterogeneity is a major obstacle to developing effective treatments for patients with primary Sjögren's syndrome. We aimed develop robust method stratification, exploiting heterogeneity in patient-reported symptoms, and relate these differences pathobiology therapeutic response.

10.1016/s2665-9913(19)30042-6 article EN cc-by The Lancet Rheumatology 2019-09-25

Abstract Metabolic programming is important for B cell fate, but the bioenergetic requirement regulatory (B reg ) differentiation and function unknown. Here we show that differentiation, unlike non-B cells, relies on mitochondrial electron transport homeostatic levels of reactive oxygen species (ROS). Single-cell RNA sequencing analysis revealed TXN , encoding metabolic redox protein thioredoxin (Trx), highly expressed by Trx inhibitor TXNIP which was downregulated. Pharmacological...

10.1038/s41590-024-01798-w article EN cc-by Nature Immunology 2024-03-29

Long non-coding RNAs (lncRNAs) are expressed in a highly tissue-specific manner and function various aspects of cell biology, often as key regulators gene expression. In this study, we established role for lncRNAs chondrocyte differentiation. Using RNA sequencing identified human articular repertoire from normal hip cartilage donated by neck femur fracture patients. Of particular interest upstream the master transcription factor SOX9 locus. is an HMG-box that plays essential development...

10.1242/dev.152504 article EN cc-by Development 2017-12-15

Irreversible breakdown of cartilage extracellular matrix (ECM) by the collagenase metalloproteinase 13 (MMP13) represents a key event in osteoarthritis (OA) progression. Although inflammation is most commonly associated with inflammatory joint diseases, it also occurs OA and thus relevant to prevalent tissue destruction. Here, generates cFOS AP-1 early response that indirectly affects MMP13 gene expression. To ascertain more direct effect on prolonged production we examined potential...

10.1074/jbc.m116.756601 article EN cc-by Journal of Biological Chemistry 2016-12-13

Objective To identify the functional single‐nucleotide polymorphisms (SNPs) and mechanisms conferring increased risk of hand osteoarthritis (OA) at ALDH1A2 locus, which is a retinoic acid regulatory gene. Methods Tissue samples from 247 patients with knee, hip, or OA who had undergone joint surgery were included. RNA‐sequencing analysis was used to investigate differential expression other signaling pathway genes in cartilage. Expression tissues obtained multiple sites quantified using...

10.1002/art.40545 article EN cc-by Arthritis & Rheumatology 2018-05-07

Many patients with rheumatoid arthritis (RA) achieve disease remission modern treatment strategies. However, having achieved this state, there are no tests that predict when withdrawal of therapy will result in drug-free rather than flare. We aimed to identify predictors RA.The Biomarkers Remission Rheumatoid Arthritis (BioRRA) Study was a unique, prospective, interventional cohort study complete and abrupt cessation conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs)....

10.1016/j.jaut.2019.06.009 article EN cc-by Journal of Autoimmunity 2019-07-04

Objective To identify methylation quantitative trait loci ( mQTL s) correlating with osteoarthritis OA ) risk alleles and to undertake mechanistic characterization as a means of target gene prioritization. Methods We used genome‐wide genotyping cartilage DNA array data in discovery screen novel loci. This was followed by methylation, expression analysis, studies additional samples, accompanied silico analyses. Results identified 4 s. The most significant contained 9 CpG sites where...

10.1002/art.40849 article EN cc-by Arthritis & Rheumatology 2019-02-07

ObjectiveLong intergenic non-coding RNAs (lincRNAs) are emerging as key regulators in gene expression; however, little is known about the lincRNA expression changes that occur osteoarthritis (OA). Here we aimed to define a transcriptome of lncRNAs OA cartilage, specifically comparing knee and hip cartilage.MethodRNA-seq was performed on nucleic acid extracted from cartilage patients undergoing joint replacement surgery because either (n = 10) or neck femur fracture (NOF; n 6). After...

10.1016/j.joca.2018.12.015 article EN cc-by Osteoarthritis and Cartilage 2019-01-03

Objective Rheumatoid arthritis ( RA ) is a genetically complex disease of immune dysregulation. This study sought to gain further insight into the genetic risk mechanisms by conducting an expression quantitative trait locus eQTL analysis confirmed loci in CD 4+ T cells and B from carefully phenotyped patients with early who were naive therapeutic immunomodulation. Methods RNA DNA isolated purified and/or obtained peripheral blood 344 arthritis. Genotyping global gene measurements carried out...

10.1002/art.40393 article EN cc-by Arthritis & Rheumatology 2017-11-29

BackgroundDefining regulatory mechanisms through which noncoding risk variants influence the cell-mediated pathogenesis of immune-mediated disease (IMD) has emerged as a priority in post–genome-wide association study era.ObjectivesWith focus on rheumatoid arthritis, we sought new insight into genetic adaptive immune dysregulation to help prioritize molecular pathways for targeting this and related pathologies.MethodsWhole-genome methylation transcriptional data from isolated CD4+ T cells B...

10.1016/j.jaci.2019.12.910 article EN cc-by Journal of Allergy and Clinical Immunology 2020-01-14

Abstract Epilepsy is a chronic and heterogenous disease characterized by recurrent unprovoked seizures, that are commonly resistant to antiseizure medications. This study applies transcriptome network-based approach across epilepsies aiming improve understanding of molecular pathobiology, recognize affected biological mechanisms apply causal reasoning identify therapeutic hypotheses. included the most common drug-resistant (DREs), such as temporal lobe epilepsy with hippocampal sclerosis...

10.1038/s41467-024-46592-2 article EN cc-by Nature Communications 2024-03-11

Objective: Dendritic cells (DCs) are key orchestrators of immune function. To date, rheumatoid arthritis (RA) researchers have predominantly focused on a potential pathogenic role for CD1c+ DCs. In contrast, CD141+ DCs and plasmacytoid (pDCs) not been systematically examined, at least in early RA. established RA the pDCs is ambiguous and, since disease duration treatment both impact pathophysiology, we examined pDCs, conventional (cDCs), early, drug-naïve (eRA) patients. Methods: We analysed...

10.3389/fimmu.2018.00755 article EN cc-by Frontiers in Immunology 2018-05-09

Abstract Regulation of transcription occurs in a cell type specific manner orchestrated by epigenetic mechanisms including DNA methylation. Methylation changes may also play key role lineage specification during stem differentiation. To further our understanding regulation chondrocytes we characterised the methylation chondrogenesis mesenchymal cells (MSCs) Infinium 450 K array. Significant hypomethylation was identified chondrogenic differentiation at many cartilage gene loci. Integration...

10.1038/s41598-020-58093-5 article EN cc-by Scientific Reports 2020-01-24

Introduction Gingival fibroblast-mediated extracellular matrix remodelling is implicated in the pathogenesis of periodontitis, yet stimuli that regulate this response are not fully understood. The immunoregulatory adipokine leptin detectable gingiva, human gingival fibroblasts express functional receptor mRNA and known to responses cardiac fibroblasts. We therefore hypothesised would enhance metalloproteinase secretion Methods Results used vitro cell culture investigate signalling effect on...

10.1371/journal.pone.0148024 article EN cc-by PLoS ONE 2016-02-01

miR-140 is selectively expressed in cartilage. Deletion of the entire Mir140 locus mice results growth retardation and early-onset osteoarthritis-like pathology; however, relative contribution miR-140-5p or miR-140-3p to phenotype remains be determined. An unbiased small RNA sequencing approach identified as significantly more abundant (>10-fold) than human Analysis these data multiple isomiRs differing from miRBase annotation at both 5′ 3′ end, with >99% having one two seed sequences...

10.1261/rna.075176.120 article EN RNA 2020-07-13

Osteoarthritis (OA) is a painful, debilitating disease characterised by loss of articular cartilage with concurrent changes in other tissues the synovial joint. Genetic association studies have shown that number common variants increase risk developing OA. Investigating their activity can uncover novel causal pathways and potentially highlight new treatment targets. One reported OA signals marked single nucleotide polymorphism (SNP) rs11842874 at chromosome 13q34. positioned within small...

10.1186/s12881-015-0254-2 article EN cc-by BMC Medical Genetics 2015-11-19

Objective: We have previously shown that increased circulating interleukin-6 (IL-6) results in enhanced CD4+ T-cell signalling via signal transduction and activator of transcription-3 (STAT3) early RA. tested the hypothesis transcriptional "imprinting" T-cells by this mechanism skews downstream effector responses, reinforcing immune dysregulation at a critical, but targetable, disease phase. Methods: modelled naïve T cell exposure to pathophysiological concentrations IL-6 vitro, assessing...

10.3389/fimmu.2019.01535 article EN cc-by Frontiers in Immunology 2019-07-03
Coming Soon ...